Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prediction errors in learning drug response from gene expression data - influence of labeling, sample size, and

Immanuel Bayer1, Philip Groth, Sebastian Schneckener

  • 1Aachen Institute for Advanced Study in Computational Engineering Science (AICES), RWTH Aachen University, Aachen, Germany.

Plos One
|July 30, 2013
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of human pharmacokinetics from chemical structure: combining mechanistic modeling with machine learning.

Journal of pharmaceutical sciences·2024
Same author

A deep neural network: mechanistic hybrid model to predict pharmacokinetics in rat.

Journal of computer-aided molecular design·2024
Same author

Emodepside targets SLO-1 channels of Onchocerca ochengi and induces broad anthelmintic effects in a bovine model of onchocerciasis.

PLoS pathogens·2021
Same author

A workflow to build PBTK models for novel species.

Archives of toxicology·2020
Same author

Bayer's in silico ADMET platform: a journey of machine learning over the past two decades.

Drug discovery today·2020
Same author

Prediction of Oral Bioavailability in Rats: Transferring Insights from in Vitro Correlations to (Deep) Machine Learning Models Using in Silico Model Outputs and Chemical Structure Parameters.

Journal of chemical information and modeling·2019
Same journal

Analysis of strength degradation of coal and rock masses and stability of mined areas under long term immersion environment.

PloS one·2026
Same journal

Biogenic Silver-Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant Staphylococcus aureus.

PloS one·2026
Same journal

Preparation and physicochemical characterization of a biodegradable chitosan/carboxymethyl cellulose hydrogel synthesized in NaOH/urea medium.

PloS one·2026
Same journal

Action-guilt, survivor-guilt, and depression in combat-related PTSD.

PloS one·2026
Same journal

Explainable machine learning for predicting activities of daily living at discharge in stroke patients: A retrospective study using SHAP interpretability.

PloS one·2026
Same journal

Deep learning based two-way feature depiction model for brain tumor detection.

PloS one·2026
See all related articles

Predicting cancer cell sensitivity to drugs depends heavily on data quality and sample size. Focusing on robust sample collection and high-quality data is more impactful than algorithm selection for accurate drug response modeling.

Area of Science:

  • Computational biology
  • Pharmacogenomics
  • Machine learning in drug discovery

Background:

  • Model-based prediction for drug response relies on numerous factors, including data collection, prediction endpoints, and algorithm parameters.
  • Predicting cancer cell line sensitivity to various compounds (e.g., IC50 values) is crucial for personalized medicine.

Purpose of the Study:

  • To investigate the impact of different choices in model-based prediction, specifically focusing on sample collection, algorithms, and prediction endpoints for drug response.
  • To compare the performance of various machine learning algorithms and labeling strategies across different sample collections.

Main Methods:

  • Utilized three independent sample collections to predict drug sensitivity (IC50) in cancer cell lines.
  • Applied multiple machine learning algorithms and compared various prediction endpoints and labeling strategies.

Related Experiment Videos

  • Evaluated model performance against identically generated null models across diverse compound and cell line combinations.

    • Main Results:

    • The predictability of treatment effects varied significantly among compounds, with some showing high predictability and others low.
    • Sample collection choice and sample size were identified as major factors in reducing prediction error.
    • No single machine learning algorithm consistently outperformed others, and no significant difference was found between regression and classification (two- or three-class) predictors.

    Conclusions:

    • Efforts in drug response modeling should prioritize enhancing sample collection and ensuring high data quality over extensive method or algorithm adjustment.
    • Robust data acquisition strategies are paramount for improving the accuracy and reliability of predictive models in cancer therapeutics.